137 related articles for article (PubMed ID: 35918785)
1. Testosterone analysis in castrated prostate cancer patients: suitability of the castration cut-off and analytical accuracy of the present-day clinical immunoassays.
van Winden LJ; Lentjes EGWM; Demir AY; Huijgen HJ; Bergman AM; van der Poel HG; van Rossum HH
Clin Chem Lab Med; 2022 Sep; 60(10):1661-1668. PubMed ID: 35918785
[TBL] [Abstract][Full Text] [Related]
2. Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancer.
van Winden LJ; Lanfermeijer M; Dezentje V; Bergman AM; van der Poel HG; van Rossum HH
Clin Chim Acta; 2023 Jan; 539():34-40. PubMed ID: 36460134
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients.
Morote J; Comas I; Ferrer R; Planas J; Celma A; Regis L
J Biomed Sci; 2017 Oct; 24(1):81. PubMed ID: 29058606
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four different immunoassays and a rapid isotope-dilution liquid chromatography-tandem mass spectrometry assay for serum folate.
Jin L; Lu Y; Yi X; Zhang M; Zhang J; Zhou W; Zeng J; Zhang T; Zhang C
Clin Chem Lab Med; 2022 Aug; 60(9):1393-1402. PubMed ID: 35675883
[TBL] [Abstract][Full Text] [Related]
5. A comparison between two different automated total 25-hydroxyvitamin D immunoassay methods using liquid chromatography-tandem mass spectrometry.
Kocak FE; Ozturk B; Isiklar OO; Genc O; Unlu A; Altuntas I
Biochem Med (Zagreb); 2015; 25(3):430-8. PubMed ID: 26526462
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Six Automated Immunoassays With Isotope-Diluted Liquid Chromatography-Tandem Mass Spectrometry for Total Thyroxine Measurement.
Yu S; Zhou W; Cheng X; Meng Q; Li H; Hou L; Lu J; Xie S; Cheng Q; Zhang C; Qiu L
Ann Lab Med; 2019 Jul; 39(4):381-387. PubMed ID: 30809984
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specifications.
van Winden LJ; Lanfermeijer M; Heijboer AC; van Tellingen O; Bergman AM; van der Poel HG; Jonker N; van Rossum HH
Clin Chim Acta; 2021 Oct; 521():70-75. PubMed ID: 34217697
[TBL] [Abstract][Full Text] [Related]
8. Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry.
Montagna G; Balestra S; D'Aurizio F; Romanelli F; Benagli C; Tozzoli R; Risch L; Giovanella L; Imperiali M
Clin Chem Lab Med; 2018 Oct; 56(11):1936-1944. PubMed ID: 29746252
[TBL] [Abstract][Full Text] [Related]
9. Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
van der Sluis TM; Bui HN; Meuleman EJ; Heijboer AC; Hartman JF; van Adrichem N; Boevé E; de Ronde W; van Moorselaar RJ; Vis AN
J Urol; 2012 May; 187(5):1601-6. PubMed ID: 22425112
[TBL] [Abstract][Full Text] [Related]
10. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods.
Farrell CJ; Martin S; McWhinney B; Straub I; Williams P; Herrmann M
Clin Chem; 2012 Mar; 58(3):531-42. PubMed ID: 22230812
[TBL] [Abstract][Full Text] [Related]
11. Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy.
Morote J; Comas I; Planas J; Maldonado X; Celma A; Placer J; Ferrer R; Carles J; Regis L
Clin Genitourin Cancer; 2018 Apr; 16(2):e491-e496. PubMed ID: 29198640
[TBL] [Abstract][Full Text] [Related]
12. Clinical Usefulness of Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Low Serum Testosterone Measurement.
Cho SE; Han J; Park JH; Park E; Kim GY; Lee JH; Yi A; Lee SG; Lee EH; Yun YM
Ann Lab Med; 2023 Jan; 43(1):19-28. PubMed ID: 36045053
[TBL] [Abstract][Full Text] [Related]
13. Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl).
van Rossum HH; van Winden LJ; Bergman AM; van der Poel HG
Eur Urol Open Sci; 2023 Feb; 48():98-100. PubMed ID: 36654783
[TBL] [Abstract][Full Text] [Related]
14. How low can you go? Analytical performance of five automated testosterone immunoassays.
La'ulu SL; Kalp KJ; Straseski JA
Clin Biochem; 2018 Aug; 58():64-71. PubMed ID: 29763574
[TBL] [Abstract][Full Text] [Related]
15. Analytical bias of automated immunoassays for six serum steroid hormones assessed by LC-MS/MS.
Debeljak Ž; Marković I; Pavela J; Lukić I; Mandić D; Mandić S; Horvat V; Šerić V
Biochem Med (Zagreb); 2020 Oct; 30(3):030701. PubMed ID: 32774123
[TBL] [Abstract][Full Text] [Related]
16. Comparison of assay methods for quantifying sex hormone concentrations across the menstrual cycle in rhesus macaques.
Fecteau KM; Winchell AJ; Blue SW; Appleman ML; Urbanski HF; Erikson DW
Biol Reprod; 2024 Apr; ():. PubMed ID: 38685627
[TBL] [Abstract][Full Text] [Related]
17. Women in sports: The applicability of reference intervals for 6 commercially available testosterone immunoassays (HemSter Study).
Radišić Biljak V; Đuras A; Čičak H; Vidranski V; Vidranski T; Peersman N; Vermeersch P; Ostroški I; Ružić L; Simundic AM
Clin Biochem; 2020 Oct; 84():55-62. PubMed ID: 32533955
[TBL] [Abstract][Full Text] [Related]
18. Lack of transferability between different immunoassays and LC-MS/MS for total 25-hydroxyvitamin D measurement and disagreement defining deficiency.
Ajuria-Morentin I; Mar-Medina C; Bereciartua-Urbieta E; Izquierdo-Quirce F; Valladares-Gómez C; Crespo-Picot E; Jaume T
Scand J Clin Lab Invest; 2013 Feb; 73(1):82-6. PubMed ID: 23171427
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of methods for quantifying serum testosterone in patients with prostate cancer who underwent castration.
Comas I; Ferrer R; Planas J; Celma A; Regis L; Morote J
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):86-93. PubMed ID: 28259362
[TBL] [Abstract][Full Text] [Related]
20. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review.
Aguilar A; Planas J; Trilla E; Morote J
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
